200 Days Left

Biomedical Catalyst 2023 Round 2

Fund Name

Biomedical Catalyst 2023 Round 2: Industry-led R&D

Project Length

6-36 months

Project Value

£150k - £4m



The aim of this competition is to support the development of innovative solutions to health and healthcare challenges.

The industry-led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. Applicants must be able to demonstrate existing evidence of commercial and technical feasibility.

Your proposal must show how your project will improve the productivity, competitiveness and growth of at least one UK micro, small or medium-sized enterprise (SME) involved in the project.

Check Your Eligibility

Fund details

Your project can include:

  • experimental evaluation at laboratory scale
  • use of in vitro and in vivo models to evaluate proof of concept or safety
  • exploring potential production mechanisms
  • prototyping
  • product development planning
  • intellectual property protection
  • a demonstration of clinical utility and effectiveness
  • a demonstration of safety and efficacy including phase 1 and 2 clinical trials
  • regulatory planning

This list is not intended to be exhaustive.

Specific themes

Your project can focus on any health or healthcare sector or discipline including:

  • biosciences
  • advanced therapies, gene and cell therapies
  • diagnostic, medical technology and devices
  • digital health
  • independent living and wellbeing
  • precision medicine
  • preclinical technologies and drug target discovery
  • therapeutic and medicine development
  • data-driven health
  • consumer health
  • preventative health

Projects Innovate UK will NOT fund

  • are fundamental research or feasibility projects
  • are not related to human life sciences
  • focus on a product that is already on the market
  • focus on laboratory accreditation
  • are conducted to anything less than the highest standards of animal welfare


Your project must:

  • have total project costs between £150,000 and £4 million
  • not exceed a grant request of £2 million
  • have at least 50% of the total project costs shared by the SMEs, if collaborative
  • start by 01 June 2024
  • end by 31 May 2027
  • last between 6 months and 36 months
  • carry out all of its project work in the UK
  • intend to exploit the results from or in the UK
Contact us